GLP-1 Natural
US$ 27.29
hims retatrutide New weight-loss drug showing stronger results than current options People Are Already Taking This
Description
And people gain the weight back when they come off it. Costs for five of the GLP-1 drugs Ozempic, Mounjaro, Wegovy, Zepbound, and Saxenda topped $300 million for Boston-based Blue Cross last year, more than double what it spent in 2023
Plus, they have dozens of other products to support your individual needs
Retatrutide is commonly discussed as a triple agonist acting on GLP-1, GIP and glucagon receptors in research contexts, especially around body-weight and metabolic signaling models
Whether GIP antagonism or agonism is the appropriate target for brain receptors is a subject to debate
